DOSEF (Doseology Sciences) Short-term investments

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DOSEF Doseology Sciences Inc DOSEF
31 GF Score
Price $0.11
GF Value $0.30
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Doseology Sciences Short-term investments?

Short-term investments only applies to insurance companies.

DOSEF
31GF Score
Doseology Sciences Inc DOSEF
Short-term investments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Doseology Sciences (DOSEF) Overvalued in 2026?

Based on GuruFocus' analysis, Doseology Sciences stock appears to be undervalued. The current stock price of $0.11 is trading 62.9% below its estimated GF Value™ of $0.30. GuruFocus considers Doseology Sciences to be Possible Value Trap.

Key valuation signals for DOSEF:

  • Short-term investments:
  • GF Value™: $0.30 vs. price of $0.11 (62.9% below fair value)
  • GF Score™: 31/100 with 5 warning signs

No single metric tells the full story. See the DOSEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Doseology Sciences Business Description

Other Exchanges MOOD:Canada
Address 9-3151 Lakeshore Road, Suite 305, Kelowna, BC, CAN, V1W 3S9
Doseology Sciences Inc is a diversified life sciences company, on a mission to reimagine mental health therapies through innovation, technology and sustainability. With a focus on the psychedelic and non-psychedelic compounds, also sale of its branded functional mushroom products. It offers cutting-edge therapeutic products and services, with the focus of making a meaningful impact on the mental health pandemic and improving overall health. Geographically earns it revenue from Canada.
31GF Score

Get the complete analysis for DOSEF

Short-term investments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.11
Price
$0.30
GF Value